Michael W. Schmitt
Cancer Research · 2012–2018
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 37 citations into it; #1,008 of 1,780 by trust here, #1,358 by citations
Whom Michael W. Schmitt trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Michael W. Schmitt overall
Papers from Michael W. Schmitt's perspective
Ordered by how strongly the researchers Michael W. Schmitt trusts endorse each paper. Same corpus, a different order for every researcher.
- Detection and quantification of rare mutations with massively parallel sequencing (Proceedings of the National Academy of Sciences of the United States of America)
- Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood (Proceedings of the National Academy of Sciences of the United States of America)
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer (Science Translational Medicine)
- Integrated digital error suppression for improved detection of circulating tumor DNA (Nature Biotechnology)
- Massively parallel functional dissection of mammalian enhancers in vivo
- Base-calling of automated sequencer traces using phred. II. Error probabilities.
- Next-generation DNA sequencing (Nature Biotechnology)
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number (Analytical Chemistry)
- PD-1 blockade induces responses by inhibiting adaptive immune resistance (Nature)
- Tracking the Evolution of Non‐Small‐Cell Lung Cancer (New England Journal of Medicine)
Their papers
- Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations (2018) — 463 citations
- Detection of ultra-rare mutations by next-generation sequencing (2012) — 980 citations